Percheron Therapeutics's market cap is currently AU$10.87M. The company's EPS TTM is AU$-0.006; its P/E ratio is ―; Percheron Therapeutics is scheduled to report earnings on August 28, 2025, and the estimated EPS forecast is AU$―. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24
Jun 23
Jun 22
Jun 21
Jun 20
Currency in AUD
Percheron Therapeutics Earnings and Revenue History
